Laboratory Corporation of America (LabCorp®) (NYSE:LH) has announced that it will participate in the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12, 2010. The company will be represented by LabCorp Chairman and Chief Executive Officer David King. Mr. King’s presentation will begin at 10:00 am PT that morning. Interested parties may listen to a webcast of the presentation online at http://www.labcorp.com/. The webcast will be archived on the site for instant replay following the conclusion of the event.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Laboratory Corporation of America Holdings is an independent clinical laboratory company. The Company has a national network of 36 primary laboratories and over 1,600 patient service centers along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain routine tests quickly and report the results to the physician immediately). Through its national network of laboratories, the Company offers a range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty testing businesses, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical trials. In August 2009, the Company completed the acquisition of Monogram Biosciences, Inc.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
